Antipsychotic drugs are central to the treatment of schizophrenia and other psychotic
disorders but are ineffective for some patients and associated with side-effects and …

Adherence to antipsychotics improves outcome in schizophrenia. There is a lack of
consensus on which factors most influence adherence behaviour and methodological …

Quality of life (QoL) has been recognized as an important outcome of schizophrenia
treatment, yet the determinants of QoL for individuals with schizophrenia are not well known …

Background In many countries of the industrialised world second generation (" atypical")
antipsychotics have become the first line drug treatment for people with schizophrenia. The …

Assessing quality of life (QoL) as a patient-reported outcome in adult psychiatry poses
challenges in terms of concepts, methods, and applications in research and practice. This …

Objective (1) determine which antipsychotic side effects (SE) schizophrenic patients
consider the most distressing during treatment with typical antipsychotics,(2) measure the …

BACKGROUND: Paradoxically, insight is associated with positive outcomes, such as better
treatment adherence and recovery, and negative outcomes, such as depression …

Schizophrenia is increasingly recognized as a neurodevelopmental disease with an
additional degenerative component, comprising cognitive decline and loss of cortical gray …

Background People with schizophrenia are at high risk of suffering from stigma and
internalizing it. Recently, a better understanding of the stigma process has shifted the …

In the last decades, there has been increased interest in the field of quality of life in mental
disorders in general, and particularly in schizophrenia. In addition, the appearance of the …